Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Skyworks Solutions Inc (SWKS) Price & Performance

Edgewise Therapeutics Inc. Common StockTrade
Skyworks Solutions IncTrade

Price performance (Past 24H)

Key statistics

Edgewise Therapeutics Inc. Common Stock vs Skyworks Solutions Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $4.02B), while Skyworks Solutions Inc trades at $76.44 (market cap $18.08B). The key difference: Skyworks Solutions Inc is far larger — about 4.5× Edgewise Therapeutics Inc. Common Stock's market cap, and Skyworks Solutions Inc pays a 4.13% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Skyworks Solutions Inc for 50 Days on average.

EWTXSWKS
Market Cap
$4.02B$18.08B
Volume
1,446,1285,128,915
Sector
HealthTechnology
52-Week High
$48.35$91.45
52-Week Low
$14.89$52.50
Typical Hold Time
0 Days50 Days
Enterprise Value
$3.56B$17.96B
Dividend Yield
—4.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Edgewise Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Skyworks Solutions Inc

Skyworks Solutions (SWKS) trades at $76.56, up 2.49% with a bearish technical signal despite recent earnings beats. The stock shows declining revenue and profit margins over recent years but maintains strong analyst support with 60% buy ratings. The pending Qorvo merger represents a significant catalyst, with regulatory clearances obtained and potential for $500 million in synergies. Current valuation metrics include a P/E of 39.68 and P/S of 2.87.

The merger with Qorvo offers substantial growth potential through expanded scale and market diversification, though integration risks and declining financial metrics warrant caution. With the current price below the $79.70 consensus target, upside exists if merger benefits materialize, but investors face execution risk and competitive pressures in the semiconductor sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWTX
100% Buy0% Sell
Avg holding period · 0 Days
SWKS
15% Buy85% Sell
Avg holding period · 50 Days

About Edgewise Therapeutics Inc. Common Stock

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.

Read more on EWTX →

About Skyworks Solutions Inc

Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.

Read more on SWKS →